University of Münster Bridges 1st Patient to Transplant with SynCardia's Total Artificial Heart
60-Year-Old German Man Receives Matching Donor Heart after 3 Months of Life with Total Artificial Heart
TUCSON, Ariz. – Aug. 17, 2011 – SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that University of Münster in Germany has successfully bridged its first patient to transplant with the Total Artificial Heart after 89 days of support.
On Jan. 14, 60-year-old Jan Detert was admitted to University of Münster as an emergency heart attack case (acute myocardial infarction). He was also suffering from a ventricular septal defect, a hole between the left and right ventricles of the heart.
Mr. Detert underwent emergency surgery that included aortocoronary bypass to create a new path to his aorta around a blocked artery, in addition to closing the hole between his heart ventricles using a patch. Two weeks after Mr. Detert's initial recovery from this surgery, he deteriorated when the ventricular septal defect recurred because his tissue had been severely weakened by the heart attack.
"SynCardia's Total Artificial Heart was our only option to save this patient's life," said Prof. Dr. Hans Scheld, Director of the Department of Thoracic and Cardiovascular Surgery. "This case demonstrates that the Total Artificial Heart is capable of bridging a patient with extended myocardial infarction, including ventricular septal defect, to successful heart transplantation."
On Jan. 30, Prof. Dr. T.D.T. Tjan and Prof. Dr. Andreas Hoffmeier implanted Mr. Detert with SynCardia's Total Artificial Heart. His condition stabilized and three months later, on April 29, he became the hospital's first patient to be successfully bridged to transplant with the Total Artificial Heart. Mr. Detert was discharged from the hospital with his new donor heart in June.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, firstname.lastname@example.org, (520) 547-7463